Gemcitabine 38 mg/mL (Gemcitabine INJECTION, SOLUTION) 38 mg/mL

Gemcitabine 38 mg/mL is an injectable solution used for various medical treatments. This intravenous medication is manufactured by Sagent Pharmaceuticals in the USA.

Strength

38 mg/mL

Pack Size

1 VIAL in 1 CARTON (25021-239-26) / 26.3 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine 38 mg/mL is primarily used in cancer treatments. It is often administered intravenously to target specific types of cancer cells. The medication works by interfering with the growth and spread of cancer cells, making it a key component in many chemotherapy regimens. Patients and healthcare providers often seek information on what is gemcitabine used for, particularly in the context of cancer therapy.

Side Effects

Common effects of gemcitabine 38 mg/mL may include fatigue, nausea, and a decreased appetite. Some patients may also experience hair loss or changes in their blood cell counts. These effects can vary widely depending on the individual and the specific treatment plan. It's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Gemcitabine 38 mg/mL should be handled with care, as it is a potent medication. It is essential to follow proper storage and administration guidelines to ensure safety. Patients should be monitored regularly for any adverse reactions. Pregnant women and individuals with certain medical conditions should exercise caution and consult their healthcare provider before use.

Avoid Interactions

Gemcitabine 38 mg/mL may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with gemcitabine, so it's best to discuss these with a healthcare professional.

Frequently Asked Questions

Gemcitabine is primarily used in cancer treatments, often as part of chemotherapy regimens.

Gemcitabine 38 mg/mL is administered intravenously by a healthcare professional.

Common side effects may include fatigue, nausea, and hair loss.

Pregnant women should consult their healthcare provider before using gemcitabine.

Gemcitabine should be stored according to the manufacturer's guidelines to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.